DONNAGEL-MB SUS 6 G / 30 ML
KAOLIN : 6 G / 30 ML PECTIN : 142.8 MG / 30 ML · DIN 01906542 · AYERST LABORATORIES
Health Canada status: CANCELLED POST MARKET
What is DONNAGEL-MB SUS?
DONNAGEL-MB SUS 6 G / 30 ML contains KAOLIN : 6 G / 30 ML PECTIN : 142.8 MG / 30 ML. It is listed in the Health Canada Drug Product Database under DIN 01906542, held by AYERST LABORATORIES, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01906542 |
|---|---|
| Brand name | DONNAGEL-MB SUS |
| Generic / active ingredient | KAOLIN : 6 G / 30 ML PECTIN : 142.8 MG / 30 ML |
| Manufacturer | AYERST LABORATORIES |
| Strength | 6 G / 30 ML |
| Dosage form | SUSPENSION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BC30 COMBINATIONS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Sep-1996 |
What can be used instead?
Other Canadian products sharing ATC code A07BC30 COMBINATIONS. 0 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIARET LIQ | 3.078 G / 30 ML | LIQUID | PRODUITS FRANCAIS LABS INC. | CANCELLED POST MARKET | DIN 00540870 |
| DIAREX | 6.156 G / 30 G | LIQUID | PHARMAVITE LABORATORIES (1987) INC. | CANCELLED POST MARKET | DIN 00411949 |
| KAOLIN AND PECTIN SUSP | 200 MG | SUSPENSION | DRUG TRADING COMPANY LTD. | CANCELLED POST MARKET | DIN 00095052 |
| KAOLIN MIXTURE W PECTIN NF | 10 MG | LIQUID | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | DIN 00238651 |
| KAOLIN PECTIN SUS | .44 % | SUSPENSION | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00412570 |
Who else supplies COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.